Oncology
Doxorubicin/Epirubicin
Doxorubicin/Epirubicin is supplied by BOOKPHARM as an active ingredient in the oncology area. Oncology active ingredients across cytotoxic and targeted classes. Business model: api supply. Listed status: EU GMP.
Supply offerings
| Business line | Business model | Regulatory status |
|---|---|---|
| APIOncology | API supply | EU GMP |
Supplied for pharmaceutical manufacturing and R&D by licensed and qualified entities. Not for human use as supplied. Availability is subject to regulatory approval in the buyer's jurisdiction.